Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.54 |
| ▸ | IDO1 | P14902 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MPO | P05164 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4886061 | 0.98 | LMNA (0.53) | LMNATAAR1IDO1KMT2AMEN1 | |
| Hydrochloric Acid SCHEMBL5074839 | 0.98 | LMNA (0.53) | LMNATAAR1IDO1KMT2AMEN1 | |
| SCHEMBL6068499 | 0.82 | MAPT (0.41) | LMNATAAR1IDO1KMT2AMEN1 | |
| Hydrochloric Acid SCHEMBL16796409 | 0.80 | MAPT (0.44) | LMNATAAR1IDO1KMT2AALDH1A1 | |
| SCHEMBL6071681 | 0.80 | MPO (0.60) | LMNATAAR1KMT2AMEN1ALDH1A1 | |
| SCHEMBL28460945 | 0.79 | ALDH1A1 (0.39) | LMNATAAR1IDO1KMT2AMEN1 | |
| SCHEMBL25588006 | 0.78 | LMNA (0.57) | LMNATAAR1IDO1KMT2AMEN1 | |
| SCHEMBL27565797 | 0.77 | TAAR1 (0.64) | LMNATAAR1IDO1KMT2AMEN1 | |
| SCHEMBL9734517 | 0.77 | LMNA (0.54) | LMNAKMT2AMEN1ALDH1A1HPGD | |
| SCHEMBL30659219 | 0.77 | LMNA (0.54) | LMNAKMT2AMEN1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 356 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120118085-A | Preparation method of Milvexian | 中国药科大学 | 2025-06-10 | — | — | CN | claimed |
| CN-116239593-B | Preparation method of vitamin Li Xigu intermediate | 上海裕兰生物科技有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-116239593-A | Preparation method of vitamin Li Xigu intermediate | 上海裕兰生物科技有限公司 | 2023-06-09 | — | — | CN | claimed |
| US-20260103457-A1 | NOVEL PROCESS FOR PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS | CYCLERION THERAPEUTICS INC (US) | 2026-04-16 | — | — | US | disclosed |
| EP-1506193-B9 | CARBAMATE-SUBSTITUTED PYRAZOLOPYRIDINES | ADVERIO PHARMA GMBH (DE) | 2026-02-18 | — | — | EP | disclosed |
| EP-1506193-B3 | CARBAMATE-SUBSTITUTED PYRAZOLOPYRIDINES | ADVERIO PHARMA GMBH (DE) | 2025-12-03 | — | — | EP | disclosed |
| US-20250361228-A1 | PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS | CYCLERION THERAPEUTICS INC (US) | 2025-11-27 | — | — | US | disclosed |
| US-20250255821-A1 | SOLID DISPERSIONS COMPRISING A SGC STIMULATOR | CYCLERION THERAPEUTICS, INC. | 2025-08-14 | — | — | US | disclosed |
| EP-4570797-A2 | NOVEL PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS | Cyclerion Therapeutics, Inc. (US) | 2025-06-18 | — | — | EP | disclosed |
| CN-116239593-B | Preparation method of vitamin Li Xigu intermediate | 上海裕兰生物科技有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-116239593-B | Preparation method of vitamin Li Xigu intermediate | 上海裕兰生物科技有限公司 | 2025-05-02 | — | — | CN | disclosed |
| WO-2000066582-A1 | SUBSTITUTED PYRAZOLE DERIVATIVE | BAYER AKTIENGESELLSCHAFT (DE) | 2000-11-09 | — | — | WO | disclosed |
| WO-2000006568-A1 | SUBSTITUTED PYRAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-02-10 | — | — | WO | disclosed |
| WO-2000006569-A1 | SUBSTITUTED PYRAZOLE DERIVATIVES CONDENSED WITH SIX-MEMBERED HETEROCYCLIC RINGS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-02-10 | — | — | WO | disclosed |
| WO-2000006567-A1 | 3-(4-AMINO-5-ETHYLPYRIMIDINE-2-YL)-1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDINE | BAYER AKTIENGESELLSCHAFT (DE) | 2000-02-10 | — | — | WO | disclosed |
| EP-0248466-B1 | PESTICIDAL TETRAZINE DERIVATIVES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1990-10-31 | — | — | EP | disclosed |
| EP-0248466-A2 | Pesticidal tetrazine derivatives | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1987-12-09 | — | — | EP | disclosed |
| US-4076943-A | DIURETICS, SALURETICS, ANTIHYPERTENSIVES | BAYER AKTIENGESELLSCHAFT (DT) | 1978-02-28 | — | — | US | disclosed |
| US-4061653-A | DIURETIC, SALURETIC, ANTIHYPERTENSIVE | BAYER AKTIENGESELLSCHAFT (DT) | 1977-12-06 | — | — | US | disclosed |
| US-3950528-A | HYPOTENSIVE AGENTS, SALURETICS, DIURETICS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361228-A1 | PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS | GUCY1A2, GUCY1B1, GUCY1B2 | LMNA 2860/4885TAAR1 3216/4885IDO1 3317/4885 |
| US-20250255821-A1 | SOLID DISPERSIONS COMPRISING A SGC STIMULATOR | GMPS, PRKG1, GUCY1A2 | LMNA 4083/4885TAAR1 3393/4885IDO1 3974/4885 |
| US-20260103457-A1 | NOVEL PROCESS FOR PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS | GUCY1B1, GUCY1B2, GUCY1A2 | LMNA 4037/4885TAAR1 2857/4885IDO1 3704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.